Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
29.40
-0.60 (-2.00%)
Apr 29, 2026, 1:54 PM CST
Genomics BioSci & Tech. Revenue
In the year 2025, Genomics BioSci & Tech. had annual revenue of 708.38M TWD with 36.86% growth. Genomics BioSci & Tech. had revenue of 220.06M in the quarter ending December 31, 2025, with 42.53% growth.
Revenue
708.38M
Revenue Growth
+36.86%
P/S Ratio
3.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 708.38M | 190.80M | 36.86% |
| Dec 31, 2024 | 517.58M | 121.44M | 30.65% |
| Dec 31, 2023 | 396.14M | -22.86M | -5.46% |
| Dec 31, 2022 | 419.00M | 29.04M | 7.45% |
| Dec 31, 2021 | 389.97M | -53.21M | -12.01% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| G&E Herbal Biotechnology | 309.13M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |
| Sunny Pharmtech | 290.18M |
| Synbio Tech | 1.04B |
| Anti-Microbial Savior BioteQ | 612.00K |
| GlycoNex Incorporation | 37.86M |
| Sinew Pharma | 47.00K |